TY - JOUR AU - Siegel, R. AU - Miller, K. AU - Jemal, A. PY - 2015 DA - 2015// TI - Cancer statistics , 2015 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21254 DO - 10.3322/caac.21254 ID - Siegel2015 ER - TY - JOUR AU - Oyer, S. L. AU - Fritsch, V. A. AU - Lentsch, E. J. PY - 2014 DA - 2014// TI - Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients JO - Ann Otol Rhinol Laryngol VL - 123 UR - https://doi.org/10.1177/0003489414523563 DO - 10.1177/0003489414523563 ID - Oyer2014 ER - TY - JOUR AU - Closs, E. I. AU - Boissel, J. P. AU - Habermeier, A. AU - Rotmann, A. PY - 2006 DA - 2006// TI - Structure and function of cationic amino acid transporters (CATs) JO - J Membr Biol VL - 213 UR - https://doi.org/10.1007/s00232-006-0875-7 DO - 10.1007/s00232-006-0875-7 ID - Closs2006 ER - TY - JOUR AU - Bhutia, Y. D. AU - Babu, E. AU - Ramachandran, S. AU - Ganapathy, V. PY - 2015 DA - 2015// TI - Amino acid transporters in cancer and their relevance to “glutamine addiction”: novel targets for the design of a new class of anticancer drugs JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-3745 DO - 10.1158/0008-5472.CAN-14-3745 ID - Bhutia2015 ER - TY - JOUR AU - Kaira, K. AU - Oriuchi, N. AU - Imai, H. AU - Shimizu, K. AU - Yanagitani, N. AU - Sunaga, N. PY - 2008 DA - 2008// TI - L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms JO - Cancer Sci VL - 99 UR - https://doi.org/10.1111/j.1349-7006.2008.00969.x DO - 10.1111/j.1349-7006.2008.00969.x ID - Kaira2008 ER - TY - JOUR AU - Elorza, A. AU - Soro-Arnáiz, I. AU - Meléndez-Rodríguez, F. AU - Rodríguez-Vaello, V. AU - Marsboom, G. AU - Cárcer, G. PY - 2012 DA - 2012// TI - HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5 JO - Mol Cell VL - 48 UR - https://doi.org/10.1016/j.molcel.2012.09.017 DO - 10.1016/j.molcel.2012.09.017 ID - Elorza2012 ER - TY - JOUR AU - Gao, P. AU - Tchernyshyov, I. AU - Chang, T. C. AU - Lee, Y. S. AU - Kita, K. AU - Ochi, T. PY - 2009 DA - 2009// TI - C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism JO - Nature VL - 458 UR - https://doi.org/10.1038/nature07823 DO - 10.1038/nature07823 ID - Gao2009 ER - TY - JOUR AU - Lewerenz, J. AU - Hewett, S. J. AU - Huang, Y. AU - Lambros, M. AU - Gout, P. W. AU - Kalivas, P. W. PY - 2013 DA - 2013// TI - The cystine/glutamate antiporter system x c− in health and disease: from molecular mechanisms to novel therapeutic opportunities JO - Antioxid Redox Signal VL - 18 UR - https://doi.org/10.1089/ars.2011.4391 DO - 10.1089/ars.2011.4391 ID - Lewerenz2013 ER - TY - JOUR AU - Network, T. C. G. A. R. AU - Agrawal, N. AU - Akbani, R. AU - Aksoy, B. A. AU - Ally, A. AU - Arachchi, H. PY - 2014 DA - 2014// TI - Integrated genomic characterization of papillary thyroid carcinoma JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.09.050 DO - 10.1016/j.cell.2014.09.050 ID - Network2014 ER - TY - JOUR AU - Elisei, R. AU - Viola, D. AU - Torregrossa, L. AU - Giannini, R. AU - Romei, C. AU - Ugolini, C. PY - 2012 DA - 2012// TI - The BRAFV600E mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2012-1775 DO - 10.1210/jc.2012-1775 ID - Elisei2012 ER - TY - JOUR AU - Prescott, J. D. AU - Sadow, P. M. AU - Hodin, R. A. AU - Le, L. P. AU - Gaz, R. D. AU - Randolph, G. W. PY - 2012 DA - 2012// TI - BRAF(V600E) status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence JO - Surgery VL - 152 UR - https://doi.org/10.1016/j.surg.2012.08.039 DO - 10.1016/j.surg.2012.08.039 ID - Prescott2012 ER - TY - JOUR AU - Virk, R. K. AU - Dyke, A. L. AU - Finkelstein, A. AU - Prasad, A. AU - Gibson, J. AU - Hui, P. PY - 2013 DA - 2013// TI - BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype–phenotype correlation JO - Mod Pathol VL - 26 UR - https://doi.org/10.1038/modpathol.2012.152 DO - 10.1038/modpathol.2012.152 ID - Virk2013 ER - TY - JOUR AU - Volante, M. AU - Rapa, I. AU - Gandhi, M. AU - Bussolati, G. AU - Giachino, D. AU - Papotti, M. PY - 2009 DA - 2009// TI - RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact JO - J Clin Endocrinol Metab VL - 94 UR - https://doi.org/10.1210/jc.2009-1233 DO - 10.1210/jc.2009-1233 ID - Volante2009 ER - TY - JOUR AU - Fukahori, M. AU - Yoshida, A. AU - Hayashi, H. AU - Yoshihara, M. AU - Matsukuma, S. AU - Sakuma, Y. PY - 2012 DA - 2012// TI - The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort JO - Thyroid VL - 22 UR - https://doi.org/10.1089/thy.2011.0261 DO - 10.1089/thy.2011.0261 ID - Fukahori2012 ER - TY - STD TI - Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000. ISBN 0-387-98784-3. ID - ref15 ER - TY - JOUR AU - Fox, J. PY - 2002 DA - 2002// TI - Cox proportional-hazards regression for survival data the cox proportional-hazards model JO - Most VL - 2008 ID - Fox2002 ER - TY - JOUR AU - Vékony, N. AU - Wolf, S. AU - Boissel, J. P. AU - Gnauert, K. AU - Closs, E. I. PY - 2001 DA - 2001// TI - Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues JO - Biochemistry VL - 40 UR - https://doi.org/10.1021/bi011345c DO - 10.1021/bi011345c ID - Vékony2001 ER - TY - JOUR AU - Yanagida, O. AU - Kanai, Y. AU - Chairoungdua, A. AU - Kim, D. K. AU - Segawa, H. AU - Nii, T. PY - 2001 DA - 2001// TI - Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines JO - Biochim Biophys Acta - Biomembr VL - 1514 UR - https://doi.org/10.1016/S0005-2736(01)00384-4 DO - 10.1016/S0005-2736(01)00384-4 ID - Yanagida2001 ER - TY - JOUR AU - Sakata, T. AU - Ferdous, G. AU - Tsuruta, T. AU - Satoh, T. AU - Baba, S. AU - Muto, T. PY - 2009 DA - 2009// TI - L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer JO - Pathol Int VL - 59 UR - https://doi.org/10.1111/j.1440-1827.2008.02319.x DO - 10.1111/j.1440-1827.2008.02319.x ID - Sakata2009 ER - TY - JOUR AU - Kobayashi, H. AU - Ishii, Y. AU - Takayama, T. PY - 2005 DA - 2005// TI - Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma JO - J Surg Oncol VL - 90 UR - https://doi.org/10.1002/jso.20257 DO - 10.1002/jso.20257 ID - Kobayashi2005 ER - TY - JOUR AU - Ichinoe, M. AU - Mikami, T. AU - Yoshida, T. AU - Igawa, I. AU - Tsuruta, T. AU - Nakada, N. PY - 2011 DA - 2011// TI - High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions JO - Pathol Int VL - 61 UR - https://doi.org/10.1111/j.1440-1827.2011.02650.x DO - 10.1111/j.1440-1827.2011.02650.x ID - Ichinoe2011 ER - TY - JOUR AU - Yanagisawa, N. AU - Ichinoe, M. AU - Mikami, T. AU - Nakada, N. AU - Hana, K. AU - Koizumi, W. PY - 2012 DA - 2012// TI - High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas JO - J Clin Pathol VL - 65 UR - https://doi.org/10.1136/jclinpath-2012-200826 DO - 10.1136/jclinpath-2012-200826 ID - Yanagisawa2012 ER - TY - STD TI - Kobayashi T, Yan H, Kurahashi Y, Ito Y, Maeda H, Tada T. Role of GalNAc4S-6ST in Astrocytic Tumor Progression. PLoS One. 2013;8(1):1–9. ID - ref23 ER - TY - JOUR AU - Kaira, K. AU - Sunose, Y. AU - Arakawa, K. AU - Ogawa, T. AU - Sunaga, N. AU - Shimizu, K. PY - 2012 DA - 2012// TI - Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer JO - Br J Cancer VL - 107 UR - https://doi.org/10.1038/bjc.2012.310 DO - 10.1038/bjc.2012.310 ID - Kaira2012 ER - TY - STD TI - Shimizu A, Kaira K, Kato M, Yasuda M, Takahashi A, Tominaga H, et al. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma. Melanoma Res. 2015;25(5). ID - ref25 ER - TY - JOUR AU - Yanagisawa, N. AU - Hana, K. AU - Nakada, N. AU - Ichinoe, M. AU - Koizumi, W. AU - Endou, H. PY - 2014 DA - 2014// TI - High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas JO - Cancer Med VL - 3 UR - https://doi.org/10.1002/cam4.272 DO - 10.1002/cam4.272 ID - Yanagisawa2014 ER - TY - STD TI - Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, Yuki H, et al. Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer. 2013;13. ID - ref27 ER - TY - JOUR AU - Polewski, M. D. AU - Reveron-Thornton, R. F. AU - Cherryholmes, G. A. AU - Marinov, G. K. AU - Aboody, K. S. PY - 2017 DA - 2017// TI - SLC7A11 overexpression in glioblastoma is associated with increased cancer stem cell-like properties JO - Stem Cells Dev VL - 26 UR - https://doi.org/10.1089/scd.2017.0123 DO - 10.1089/scd.2017.0123 ID - Polewski2017 ER - TY - JOUR AU - Robert, S. M. AU - Buckingham, S. C. AU - Campbell, S. L. AU - Robel, S. AU - Holt, K. T. AU - Ogunrinu-Babarinde, T. PY - 2015 DA - 2015// TI - SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa8103 DO - 10.1126/scitranslmed.aaa8103 ID - Robert2015 ER - TY - JOUR AU - Takeuchi, S. AU - Wada, K. AU - Toyooka, T. AU - Shinomiya, N. AU - Shimazaki, H. AU - Nakanishi, K. PY - 2013 DA - 2013// TI - Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas JO - Neurosurgery VL - 72 UR - https://doi.org/10.1227/NEU.0b013e318276b2de DO - 10.1227/NEU.0b013e318276b2de ID - Takeuchi2013 ER - TY - JOUR AU - Polewski, M. D. AU - Reveron-Thornton, R. F. AU - Cherryholmes, G. A. AU - Marinov, G. K. AU - Cassady, K. AU - Aboody, K. S. PY - 2016 DA - 2016// TI - Increased expression of system xc- in glioblastoma confers an altered metabolic state and temozolomide resistance JO - Mol Cancer Res VL - 14 UR - https://doi.org/10.1158/1541-7786.MCR-16-0028 DO - 10.1158/1541-7786.MCR-16-0028 ID - Polewski2016 ER - TY - JOUR AU - Timmerman, L. A. AU - Holton, T. AU - Yuneva, M. AU - Louie, R. J. AU - Padró, M. AU - Daemen, A. PY - 2013 DA - 2013// TI - Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target JO - Cancer Cell VL - 24 UR - https://doi.org/10.1016/j.ccr.2013.08.020 DO - 10.1016/j.ccr.2013.08.020 ID - Timmerman2013 ER - TY - JOUR AU - Roh, J. L. AU - Kim, E. H. AU - Jang, H. AU - Shin, D. PY - 2017 DA - 2017// TI - Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition JO - Free Radic Biol Med VL - 104 UR - https://doi.org/10.1016/j.freeradbiomed.2017.01.002 DO - 10.1016/j.freeradbiomed.2017.01.002 ID - Roh2017 ER - TY - STD TI - Yoon BR, Oh YJ, Kang SW, Lee EB, Lee WW. Role of SLC7A5 in metabolic reprogramming of human monocyte/macrophage immune responses. Front Immunol. 2018;9:53. ID - ref34 ER - TY - JOUR AU - Kandasamy, P. AU - Gyimesi, G. AU - Kanai, Y. AU - Hediger, M. A. PY - 2018 DA - 2018// TI - Amino acid transporters revisited: new views in health and disease JO - Trends Biochem Sci VL - 43 UR - https://doi.org/10.1016/j.tibs.2018.05.003 DO - 10.1016/j.tibs.2018.05.003 ID - Kandasamy2018 ER - TY - JOUR AU - Naoum, G. E. AU - Morkos, M. AU - Kim, B. AU - Arafat, W. PY - 2018 DA - 2018// TI - Novel targeted therapies and immunotherapy for advanced thyroid cancers JO - Mol Cancer Mol Cancer VL - 17 UR - https://doi.org/10.1186/s12943-017-0753-1 DO - 10.1186/s12943-017-0753-1 ID - Naoum2018 ER -